Clinical Trial Update: Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effects of lithium and divalproex on brain-derived neurotrophic factor in Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Divalproex (divalproex sodium)
• Lithium (Lithium carbonate)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED